by jenerasmus | Mar 11, 2020 | Blog
This is the third installment of a three-part blog series on Complex Innovative Trial Designs. As we’ve discussed previously, clinical trials are evolving rapidly, with new data sources and medical innovation increasing the complexity of study designs. The FDA has...
by jenerasmus | Feb 24, 2020 | Blog
As discussed in our last blog, with advances in medical science and new data sources, study design complexity is on the rise. The US FDA continues to show interest and support for these new and innovative science and clinical trial designs, initiating programs and...
by jenerasmus | Feb 13, 2020 | Blog
As medical science continues to advance and new technologies and data sources emerge, the US FDA continues to show interest and support for innovative science and clinical trial designs. The agency has committed to increasing the capacity of their internal teams...
by jenerasmus | Jan 30, 2020 | Blog, Case Studies
As clinical trials become increasingly complex with a growing pressure to build and execute studies as quickly as possible, getting a study set up and running quickly is paramount to success. We continually work to enhance iMednet’s user experience and we frequently...
by jenerasmus | Jan 14, 2020 | Blog
As discussed in our last blog, we see three BIG trends impacting clinical trials and how they are conducted. As the clinical trials industry rapidly evolves, we anticipate these trends to not only continue, but potentially grow, in the foreseeable future. They are:...
by jenerasmus | Jan 7, 2020 | Blog
As the calendar turns to 2020, it not only marks the beginning of a new decade, but it also marks what will soon be the beginning of the third decade since Mednet was founded in 2001. Much has changed since then, particularly in the past 10 years. As we enter a new...
